Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma
Public ClinicalTrials.gov record NCT00061672. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to assess the safety and effectiveness of ABT-510 in subjects with refractory lymphoma.
Study identification
- NCT ID
- NCT00061672
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 67 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2003 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Aug 15, 2007
Started 2003
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hematology Oncology Associates | Phoenix | Arizona | 85012 | — |
| Arizona Clinical Research Center | Tucson | Arizona | 85712 | — |
| USC - Norris Cancer Center | Los Angeles | California | 90033 | — |
| The Center for Hematology-Oncology | Boca Raton | Florida | 33486 | — |
| Oncology-Hematology Group of South Florida | Miami | Florida | 33176 | — |
| Cancer Centers of Florida, P.A. | Orlando | Florida | 32806 | — |
| Kansas City Oncology and Hematology Group | Kansas City | Missouri | 64111 | — |
| Arch Medical Services, INC. | St Louis | Missouri | 63142 | — |
| Albany Regional Cancer Center | Albany | New York | 12208 | — |
| Raleigh Hematology Oncology Clinic | Cary | North Carolina | 27511 | — |
| The West Cancer Clinic | Memphis | Tennessee | 38120 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Hematology Oncology Associates | San Antonio | Texas | 78229 | — |
| U of W - Comprehensive Care Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00061672, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2007 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00061672 live on ClinicalTrials.gov.